Q2 2026 · Form 13F LedgerData source: SEC EDGAR  
H

HOLDER.TOP

Who owns what — the quarterly ledger of U.S. institutional holdings.
EN · 简 · 繁
Funds / Vivo Capital, LLC
Form 13F · Q2 2026

Vivo Capital, LLC

CIK 1674712Filed 2026-08-1413F-HR View the filing on EDGAR ↗
$1.1B
Reported book value
47
Positions
12
Quarters on record
Top 50
Positions

Vivo Capital, LLC — holdings

Top 47 positions of 47, ranked by reported value. Share change is versus the previous quarter.
#SecuritySharesShare Δ QoQValue% of book
1TRVI Trevi Therapeutics Inc5.1M+0.0%$95M8.7%
2PRAX Praxis Precision Medicines I271,116−20.0%$91M8.3%
3ERAS Erasca Inc4.1M−66.0%$76M6.9%
4AVBP Arrivent Biopharma Inc1.7M+89.9%$58M5.3%
5ABIVAX SA Abivax Sa414,899+73.2%$55M5.0%
6TNGX Tango Therapeutics Inc1.4M−36.0%$43M3.9%
7CRVS Corvus Pharmaceuticals Inc2.8M+0.0%$42M3.8%
8DRUG Bright Minds Biosciences Inc557,172+0.0%$39M3.6%
9SVA Sinovac Biotech Ltd5.9M+0.0%$38M3.5%
10TENX Tenax Therapeutics Inc2.5M+1100.0%$36M3.3%
11ACRS Aclaris Therapeutics Inc6.7M+0.4%$35M3.2%
12DYN Dyne Therapeutics Inc1.6M+0.0%$35M3.2%
13DNTH Dianthus Therapeutics Inc353,998+0.0%$35M3.2%
14ANRO Alto Neuroscience Inc1.2M+16.7%$32M2.9%
15DBVT Dbv Technologies S A1.8M−30.8%$30M2.8%
16SABS Sab Biotherapeutics Inc7.3M−36.1%$28M2.6%
17MLTX Moonlake Immunotherapeutics1.4M+40.0%$27M2.5%
18LBRX Lb Pharmaceuticals Inc800,000+0.0%$26M2.4%
19NERV Minerva Neurosciences Inc4.3M+0.0%$24M2.2%
20DSGN Design Therapeutics Inc1.6M+0.0%$23M2.1%
21ORIC Oric Pharmaceuticals Inc1.8M+0.0%$20M1.8%
22CAMP Camp4 Therapeutics Corp4.2M+0.0%$19M1.7%
23FTH Faeth Therapeutics Inc722,020+0.0%$18M1.6%
24QUIT Achieve Life Science Inc2.8M—$18M1.6%
25CMPX Compass Therapeutics Inc7.8M−18.7%$17M1.6%
26ANTX An2 Therapeutics Inc3.2M+0.0%$15M1.4%
27EDIT Editas Medicine Inc3.6M—$12M1.1%
28GERN Geron Corp8.7M+0.0%$11M1.0%
29ODTX Odyssey Therapeutics Inc575,000—$11M1.0%
30EPRX Eupraxia Pharmaceuticals Inc1.4M+0.0%$9M0.8%
31OKUR Onkure Therapeutics Inc1.9M+0.0%$9M0.8%
32OLEMA PHARMACEUTICALS INC Olema Pharmaceuticals Inc671,843+0.0%$8M0.8%
33MNPR Monopar Therapeutics Inc90,500+0.0%$8M0.8%
34AURA Aura Biosciences Inc1.2M—$8M0.8%
35SRZN Surrozen Inc260,000+0.0%$7M0.6%
36ALXO Alx Oncology Hldgs Inc3.2M+0.0%$7M0.6%
37MSLE Satellos Bioscience Inc813,666+0.0%$6M0.6%
38AVTX Avalo Therapeutics Inc275,000—$5M0.5%
39PEPG Pepgen Inc2.3M+0.0%$4M0.4%
40VALN Valneva Se763,199—$4M0.4%
41SERA Sera Prognostics Inc1.7M+0.0%$3M0.3%
42UNCY Unicycive Therapeutics Inc550,000−69.3%$3M0.2%
43TIL Instil Bio Inc292,743+0.0%$2M0.2%
44MTRI Inmed Pharmaceuticals Inc798,377—$1M0.1%
45BOLT Bolt Biotherapeutics Inc72,414+0.0%$278,7940.0%
46KTTA Pasithea Therapeutics Corp465,471−77.8%$239,9040.0%
47DTIL Precision Biosciences Inc4,675+0.0%$36,7460.0%
Source: Form 13F filings via SEC EDGAR. Positions as of Jun 30, 2026. Options (put/call) are excluded from share counts.